« Back to Team
Chief Executive Officer

Justin Mika, MBA, MS


Entrepreneur In Residence, University Health Network
Board Member, PhenoVista
CEO, AlivaMab Discovery Services
SVP, Eurofins
SVP and Chief Commercial Lead, DiscoverX (acquired by Eurofins)

Justin is the Chief Executive Officer of AbTherx. He has served in executive and advisory roles in biotechnology, drug discovery platform, and healthcare investment organizations for over 15 years. His most recent position was CEO of AlivaMab Discovery Services (ADS), where he led the organization through a period of rapid growth. Before ADS, Justin was the Senior Vice President of the Eurofins Drug Discovery division, where his scope included leading strategy across nine global sites, innovation, and M&A. Before Eurofins, Justin led the Drug Discovery Service division of DiscoverX, including the acquisitions of Ambit Bioscience’s KINOMEscan platform and Asterand’s BioSeek platform. In 2017, DiscoverX was acquired by Eurofins.

Justin received his MBA and MS from the University of Delaware and his BSc from Penn State University.